Piotr Popik

Piotr Popik publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Piotr Popik sits on this spectrum.

Piotr Popik D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Piotr Popik sits on this spectrum.

Research.com Recognitions

• 2026 - Research.com Neuroscience in Poland Leader Award

Best Publications

• Glutamate-based antidepressants: 20 years on

  Phil Skolnick;Piotr Popik;Piotr Popik;Ramon Trullas

  459
  Citations

• Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.

  P. Skolnick;R. T. Layer;P. Popik;G. Nowak

  424
  Citations

• Adenosine A3 receptor stimulation and cerebral ischemia

  Dag K.J.E. Von Lubitz;Rick C.-S. Lin;Piotr Popik;Margaret F. Carter

  335
  Citations

• Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.

  I A Paul;G Nowak;R T Layer;P Popik

  318
  Citations

• Low doses of oxytocin facilitate social recognition in rats.

  Piotr Popik;Jerzy Vetulani;Jan M. van Ree

  267
  Citations

• 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

  P Popik;R T Layer;P Skolnick

  263
  Citations

• Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.

  Marcin Siwek;Dominika Dudek;Ian A. Paul;Magdalena Sowa-Kućma

  256
  Citations

• Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

  I.V. Belozertseva;T. Kos;P. Popik;W. Danysz

  230
  Citations

• Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor

  Phil Skolnick;Piotr Popik;Aaron Janowsky;Bernard Beer

  222
  Citations

• The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

  Adam Bisaga;Sandra D. Comer;Amie S. Ward;Piotr Popik

  178
  Citations

• Oxytocin but not vasopressin facilities social recognition following injection into the medial preoptic area of the rat brain

  Piotr Popik;Jan M. van Ree

  167
  Citations

• Laughing Rats Are Optimistic

  Rafal Rygula;Helena Pluta;Piotr Popik;Piotr Popik

  166
  Citations

• In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists

  Adam Bisaga;Piotr Popik

  165
  Citations

• Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)

  Richard T. Layer;Piotr Popik;Tia Olds;Phil Skolnick

  164
  Citations

• The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence

  Piotr Popik;Phil Skolnick

  159
  Citations

• Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist.

  P Popik;M Wróbel

  151
  Citations

• Serum zinc level in depressed patients during zinc supplementation of imipramine treatment.

  Marcin Siwek;Dominika Dudek;Małgorzata Schlegel-Zawadzka;Agnieszka Morawska

  150
  Citations

• Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models.

  Aleksandra Kłodzińska;Ewa Chojnacka-Wójcik;Agnieszka Pałucha;Piotr Brański

  149
  Citations

• Inhibition of Reinforcing Effects of Morphine and Motivational Aspects of Naloxone-Precipitated Opioid Withdrawal by N-Methyl-d-aspartate Receptor Antagonist, Memantine

  Piotr Popik;Wojciech Danysz

  149
  Citations

• NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

  P Popik;R T Layer;L H Fossom;M Benveniste

  139
  Citations